The Data
/
Stocks
/ GBFH
Equity · Financial Services
GBFH
NASDAQ
GBank Financial Holdings Inc.
$31
−3.08% vs prior close
Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
1D
1M
3M
1Y
5Y
All
Price · Chart
Our own end-of-day closes
11 sessions
The line runs $32 on 2 July through $31 on 17 July, on a scale from $30 to $33. Days the market did not trade hold the previous close, flat.
Interactive GBFH price chart by TradingView (requires JavaScript).
The chart above plots the price of GBFH over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 11 sessions over that window: $32 on 2 July 2026 through $31 on 17 July 2026.
Market cap
$450.0M
52-week range
$24.73 – $43.57
Avg volume
10.2K
Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026
About GBank Financial Holdings Inc.
GBank Financial Holdings Inc. (GBFH) trades on NasdaqCM in the financial services sector. The figures on this page are the crowd reading — Reddit mention volume and crowd sentiment over a rolling window — alongside a reference price. They are a sentiment signal, not investment advice.
Company
Exchange
NasdaqCM
Sector
Financial Services
Class
Equity
Insiders Form 4
Filings 4 sets
GBFH has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 5 December 2025.
Date
Insider
Type
Shares
Value
11 Nov 2025
Griege Charles William Jr.
Buy
25,000
$833K
07 Nov 2025
NIGRO EDWARD MICHAEL
Executive Chairman
Buy
200
$7K
03 Nov 2025
Campbell Tara Allyce
EVP/COO of GBank
Sell
3,867
$138K
15 Sep 2025
Levine Scot Michael
EVP, CRO (GBank)
Sell
5,650
$221K
12 Sep 2025
Levine Scot Michael
EVP, CRO (GBank)
Sell
2,350
$92K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Date
Insider
Type
Shares
Value
05 Dec 2025
HORNBUCKLE WILLIAM
Gift
100,000
01 Oct 2025
Griege Charles William Jr.
Award
179
$7K
01 Oct 2025
Sklar Alan Curtis
Award
166
$7K
01 Oct 2025
Nigro Todd Anthony
SECRETARY
Award
179
$7K
01 Oct 2025
Finley Alfred Lee
Award
141
$6K
01 Oct 2025
Voinovich Michael C
Award
251
$10K
01 Oct 2025
HORNBUCKLE WILLIAM
Award
148
$6K
01 Oct 2025
SIMS JAMES K
Award
173
$7K
01 Oct 2025
LEVER KATHRYN S
Award
173
$7K
12 Sep 2025
Levine Scot Michael
EVP, CRO (GBank)
Option exercise
8,000
$162K
GBFH reported financials
SEC EDGAR XBRL
GBFH reported revenue of $1.2B for the fiscal year ended 31 Dec 2025. Net income over the same period was $20.9M.
Figure
Reported
Period
Revenue
$1.2B
31 Dec 2025
fiscal year
Net income
$20.9M
31 Dec 2025
fiscal year
Diluted EPS
$1.44
31 Dec 2025
fiscal year
Total assets
$1.4B
30 Jun 2026
at period end
Total equity
$172.8M
30 Jun 2026
at period end
Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
GBFH earnings
SEC EDGAR
Date
Period
EPS
Revenue
30 Jun 2026
Q2 2026
$0.38
—
31 Mar 2026
Q1 2026
$0.09
—
31 Dec 2025
FY 2025
$1.44
$1.24B
30 Sep 2025
Q3 2025
$0.30
—
30 Jun 2025
Q2 2025
$0.33
—
31 Mar 2025
Q1 2025
$0.31
—
31 Dec 2024
FY 2025
$1.39
—
30 Sep 2024
Q3 2025
$0.38
—
Next report no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
4 of the 45 institutional funds we track reported a GBFH position for the quarter ended 30 Jun 2026 — a combined $6.9M; the latest of those filings landed 02 Sep 2026.
Source: SEC EDGAR 13F filings
GBFH fails-to-deliver
SEC CNS data
On 27 Aug 2026, 632 shares of GBFH failed to deliver (about $13K) — the latest of 5 consecutive trading days with recorded fails.
Settlement date
Shares failed
Notional
% of shares out
27 Aug 2026
632
$13K
0.004%
26 Aug 2026
371
$8K
0.003%
25 Aug 2026
5
$107
<0.001%
24 Aug 2026
190
$4K
0.001%
21 Aug 2026
54
$1K
<0.001%
18 Aug 2026
3,414
$72K
0.024%
Source: SEC fails-to-deliver (CNS) data